Todd Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 4,375 shares at $26.12 ($114K) on 2026-08-03, disclosed to the SEC on 2026-08-05.
Open-market sale of $114k ARQT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARQT | SELL | 2026-02-04 | $506K | — | Filing → |
| ARQT | SELL | 2025-11-24 | $3.0M | — | Filing → |
| ARQT | SELL | 2025-11-05 | $569K | — | Filing → |